Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Alerany

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Clinical Medicine|November 13, 2021
Off-Label Use of Rituximab in Patients with Different Types of Nephropathies in a Tertiary Hospital: A Retrospective StudyCarla Sans-Pola, Antònia Agustí, Josep Àngel Bosch, et al.
Advances in Therapy|October 24, 2025
Value Contribution of Palopegteriparatide in Adult Patients with Chronic Hypoparathyroidism using Multicriteria Decision Analysis (MCDA)Juan José Díez, Xavier Badia, Reyes Abad, et al.
Global & Regional Health Technology Assessment|January 30, 2025
Value contribution of leniolisib in the Treatment of Activated PI3Kδ syndrome (APDS) in Spain using Multi-Criteria Decision Analysis (MCDA)María Reyes Abad, Carmen Alerany, Luis Ignacio González, et al.
Global & Regional Health Technology Assessment|May 24, 2024
Determining value in the treatment of activated PI3Kδ syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholdersMaría Reyes Abad, Carmen Alerany, Laia Alsina, et al.
Orphanet Journal of Rare Diseases|January 28, 2025
Identification of strengths and weaknesses of the healthcare system for persons living with rare diseases in Catalonia (Spain), and recommendations to improve its comprehensive attention: the "acERca las enfermedades raras" projectJosé Hernández-Rodríguez, Fernando Martínez-Valle, Xènia Acebes, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Clinical Medicine|November 13, 2021
Off-Label Use of Rituximab in Patients with Different Types of Nephropathies in a Tertiary Hospital: A Retrospective StudyCarla Sans-Pola, Antònia Agustí, Josep Àngel Bosch, et al.
Advances in Therapy|October 24, 2025
Value Contribution of Palopegteriparatide in Adult Patients with Chronic Hypoparathyroidism using Multicriteria Decision Analysis (MCDA)Juan José Díez, Xavier Badia, Reyes Abad, et al.
Global & Regional Health Technology Assessment|January 30, 2025
Value contribution of leniolisib in the Treatment of Activated PI3Kδ syndrome (APDS) in Spain using Multi-Criteria Decision Analysis (MCDA)María Reyes Abad, Carmen Alerany, Luis Ignacio González, et al.
Global & Regional Health Technology Assessment|May 24, 2024
Determining value in the treatment of activated PI3Kδ syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholdersMaría Reyes Abad, Carmen Alerany, Laia Alsina, et al.
Orphanet Journal of Rare Diseases|January 28, 2025
Identification of strengths and weaknesses of the healthcare system for persons living with rare diseases in Catalonia (Spain), and recommendations to improve its comprehensive attention: the "acERca las enfermedades raras" projectJosé Hernández-Rodríguez, Fernando Martínez-Valle, Xènia Acebes, et al.
Pageof 1